Recursion Pharmaceuticals Faces Cash Burn and Pipeline Uncertainty Amid Partnership Milestones

Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) has turned its AI‑driven discovery engine into a double‑edged sword: w...

Read story →